Ida Khodami

Ida Khodami is a Partner based in San Diego with expertise in genomics, biotech, and operations. Ida joined TBC from Illumina, where she held multiple leadership positions across Engineering and Operations for over a decade. She built and led the first company validation consortium that resulted in FDA approval for the first-ever Next-Generation- Sequencing platform: MiSeqDX. Over the past three years, she has led the global business strategy and operations for the Direct-to-Consumer genomics market. Ida has an M.Sc from University of Waterloo in Electrical Engineering and Computer Science.